Coverage
-
July 27, 2017
A genetics company and a mother who filed a proposed class action claiming the company misrepresented the accuracy of its tests for determining a baby's sex have resolved their dispute, according to a Thursday filing in California federal court.
1 other articles on this case.
View all »